This Stock Looks Poised for a Surge

The biopharmaceutical company that discovers and develops therapeutic candidates for neurodegenerative diseases in the United States, Denali Therapeutics Inc. (NASDAQ: DNLI) seems to be gearing up for a surge as per its latest charts.

Bullish Indications

#1 Ascending triangle pattern Breakout: DNLI’s daily chart shows that the stock had recently formed an Ascending Triangle pattern. An Ascending Triangle pattern is a bullish pattern. This is marked on the daily chart in pink color. A breakout from an ascending triangle pattern generally indicates the start of a bullish trend. The breakout level also acts as a good support level. Currently, the stock has broken out of the ascending triangle pattern, which is a possible bullish sign.

Daily Chart – DNLI

#2 Trading Above MAs: The stock is currently trading above both its 50-day and 200-day SMA, which implies that the bulls are currently in control.

#3 MACD Above Signal Line: In the daily chart, the MACD line (light blue color) is currently above the MACD signal line (orange color) which is typically considered as a bullish bias.

#4 Bullish ADX and DI: The ADX indicator shows bullishness because (+DI) is greater than (-DI), and ADX is rising from below both (+DI) and (-DI).

#5 Bullish Stochastic: The %K (blue) line of stochastic is currently above the %D (Orange) line in the daily chart. It is also moving higher from oversold levels. This is a possible bullish indication.

#6 Consolidation Area Breakout: The weekly chart shows that the stock was consolidating within a price range for the past several months. This area is marked as a purple color rectangle. The stock has now broken out from this consolidation area and is currently trading above it. The breakout level of this consolidation area typically acts as a good support level.

Weekly Chart – DNLI

#7 MACD above Signal Line: In the weekly chart as well, the MACD line is above the MACD signal line which is a bullish signal. The stock is also trading above its 50-week SMA, indicating that the bulls are still in control.

Premium Content

Recommended Trade (based on the charts)

Buy Levels: If you want to get in on this trade, the recommended buy level for DNLI is if the stock retests to the breakout level of the ascending triangle pattern at around $29. However, for those with higher risk appetite, you can purchase half the intended quantity of shares if it trades above yesterday’s close, at around $31.70.

TP: Our target prices are $37 and $45 based on the breakout from the Ascending Triangle pattern.

SL: To limit risk, place a stop loss near $23.60 (for entry near $29) and $28.40 (for entry near $31.70). Note that this stop loss is on a closing basis.

Our target potential upside is 17% to 55% in the next 4-6 months.

  • Entry at $29: For a risk of $5.40, the target rewards are $8.00 and $16.00. This is a nearly 1:2 and 1:3 risk-reward trade.
  • Entry at $31.70: For a risk of $3.30, the target rewards are $5.30 and $13.30. This is a nearly 1:2 and 1:4 risk-reward trade.

In other words, this trade offers nearly 2x to 4x more potential upside than downside.

Risks to Consider
The stock may reverse its overall trend if it breaks down with high volume from the ascending triangle pattern. The sell-off of the stock could also be triggered in case of any negative news, overall weakness in the market, or any regulatory changes in its sector.

Happy Trading!

— Tara

This is the #1 Stock to Buy for the AI Tidal Wave [sponsor]
Marc Chaikin warned people about NVDA before its 2023 bull run - now he's naming his next pick or the AI tidal wave. Learn more here.
Premium Content